Merck: This Cancer-Drug Powerhouse Could Be a Core Dividend
A dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Base value in index level serves as an anchor point for comparisons across periods, clarifying gains, losses, and scale.
23,806 articlesA dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Bitcoin faces a fresh test as five straight weeks of spot ETF withdrawals drain billions. Miners liquidate, bids thin...
A London-based startup is funding a hardware-agnostic AI workload platform with $10.25 million in fresh capital, back...
With the 2026 midterms approaching, crypto markets face shifting liquidity and policy bets that could drive a notable...
Redwire posted a strong revenue beat but a bigger-than-expected loss, triggering a mid-day rally in its stock. This a...
Private and public sector leaders warn that Iran is expanding its AI-enabled cyber toolkit, raising the risk to banks...
A high-income household aims to retire at 58 with $3.4 million, keeping tax-advantaged accounts untouched. Experts we...
A court ruling over a $175 billion tariff scheme puts refunds on hold, widening the gap between import costs and cons...
A wave of Wall Street financing is turning public Bitcoin miners into power-and-compute operators, as bitcoin mining ...
Conflicts in the Persian Gulf threaten the region’s desalination network, risking drinking water supplies for million...
A group of lesser-known dividend ETFs is delivering stronger income and price gains as investors seek stability in a ...
Bitcoin trades near the mid-$60,000s after testing $70,000 earlier this week. Analysts say long-term holder activity ...